Trxade Ebit Per Revenue from 2010 to 2024

MEDS Stock  USD 7.59  0.35  4.83%   
Trxade Ebit Per Revenue yearly trend continues to be comparatively stable with very little volatility. Ebit Per Revenue is likely to outpace its year average in 2024. From the period from 2010 to 2024, Trxade Ebit Per Revenue quarterly data regression had mean square error of  0.37 and mean deviation of  0.42. View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
(0.88)
Current Value
(0.83)
Quarterly Volatility
0.58698451
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Trxade financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Trxade's main balance sheet or income statement drivers, such as Interest Expense of 1.3 M, Selling General Administrative of 4.8 M or Other Operating Expenses of 8.8 M, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0 or PTB Ratio of 6.96. Trxade financial statements analysis is a perfect complement when working with Trxade Valuation or Volatility modules.
  
Check out the analysis of Trxade Correlation against competitors.

Latest Trxade's Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of Trxade Group over the last few years. It is Trxade's Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Trxade's overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Very volatile
   Ebit Per Revenue   
       Timeline  

Trxade Ebit Per Revenue Regression Statistics

Arithmetic Mean(0.45)
Coefficient Of Variation(131.57)
Mean Deviation0.42
Median(0.20)
Standard Deviation0.59
Sample Variance0.34
Range2.315
R-Value0.03
Mean Square Error0.37
R-Squared0.001
Significance0.91
Slope0
Total Sum of Squares4.82

Trxade Ebit Per Revenue History

2024 -0.83
2023 -0.88
2022 -0.24
2021 -0.54
2020 -0.1
2019 0.0761
2018 -0.0229

About Trxade Financial Statements

Trxade shareholders use historical fundamental indicators, such as Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Although Trxade investors may analyze each financial statement separately, they are all interrelated. The changes in Trxade's assets and liabilities, for example, are also reflected in the revenues and expenses on on Trxade's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Ebit Per Revenue(0.88)(0.83)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Trxade Stock Analysis

When running Trxade's price analysis, check to measure Trxade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trxade is operating at the current time. Most of Trxade's value examination focuses on studying past and present price action to predict the probability of Trxade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trxade's price. Additionally, you may evaluate how the addition of Trxade to your portfolios can decrease your overall portfolio volatility.